Cargando…

Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo

Aim: Most statins increase the risk of new-onset diabetes. Unlike other statins, pitavastatin is reported to exert neutral effects on serum glucose level, but the precise mechanism is unknown. Methods: Eight-week-old male C57BL/6J mice (n = 26) were fed high-fat diet (HFD, 45% fat) with 0.01% placeb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Yongin, Lee, Hyangkyu, Park, Hyun Ki, Choe, Eun Yeong, Wang, Hye Jin, Kim, Ryeong-Hyeon, Kim, Youjin, Kang, Eun Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242225/ https://www.ncbi.nlm.nih.gov/pubmed/31527323 http://dx.doi.org/10.5551/jat.50039

Ejemplares similares

Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue
por: Cho, Yongin, et al.
Publicado: (2020)

Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial
por: Park, Jun-Bean, et al.
Publicado: (2017)

Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases
por: Seo, Won-Woo, et al.
Publicado: (2022)

In Vivo Enrichment of Diabetogenic T Cells
por: Thelin, Martin A., et al.
Publicado: (2017)

Pitavastatin suppressed liver cancer cells in vitro and in vivo
por: You, He-Yi, et al.
Publicado: (2016)

DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
por: Kim, Youjin, et al.
Publicado: (2022)

Very rapid effect of pitavastatin on microvascular function in comparison to rosuvastatin: reactive hyperemia peripheral arterial tonometric study
por: Kono, Yasushi, et al.
Publicado: (2013)

Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study
por: Liu, Wei-Ting, et al.
Publicado: (2020)

Diabetogene Umweltfaktoren
por: Wabnitz, Katharina, et al.
Publicado: (2022)

Multilayer-Coated Tablet of Clopidogrel and Rosuvastatin: Preparation and In Vitro/In vivo Characterization
por: Seo, Ki-Soo, et al.
Publicado: (2019)

Chitosan-Tripolyphosphate Nanoparticles Prepared by Ionic Gelation Improve the Antioxidant Activities of Astaxanthin in the In Vitro and In Vivo Model
por: Kim, Eun Suh, et al.
Publicado: (2022)

Statin diabetogenicity: guidance for clinicians
por: Ray, Kausik
Publicado: (2013)

In Vitro Effect of Pitavastatin and Its Synergistic Activity with Isavuconazole against Acanthamoeba castellanii
por: Hahn, Hye Jee, et al.
Publicado: (2020)

Pleiotropic effects of pitavastatin
por: Davignon, Jean
Publicado: (2012)

In vivo and In vitro Drug Interactions Study of Glimepride with Atorvastatin and Rosuvastatin
por: Galani, VJ, et al.
Publicado: (2010)

Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
por: Han, Eugene, et al.
Publicado: (2017)

The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
por: Choe, Eun Yeong, et al.
Publicado: (2014)

Epigenetic regulation of diabetogenic adipose morphology
por: Kerr, A.G., et al.
Publicado: (2019)

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
por: Kang, Woo Youl, et al.
Publicado: (2018)

Interaction of the pitavastatin with model membranes
por: Shurshalova, Guzel S., et al.
Publicado: (2021)

Assessing Impact of High-Dose Pitavastatin on Carotid Artery Elasticity with Speckle-Tracking Strain Imaging
por: Kim, Chee Hae, et al.
Publicado: (2018)

Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients at Cardiovascular Risk
por: Yang, Yujin, et al.
Publicado: (2021)

Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
por: Cho, Yongin, et al.
Publicado: (2019)

Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study)
por: Jeong, In-Kyung, et al.
Publicado: (2020)

Diabetogenic Potential of Ancestral and Modern Wheat Landraces
por: Aguayo-Patrón, Sandra V., et al.
Publicado: (2017)

Diabetogenic Effects of Ochratoxin A in Female Rats
por: Mor, Firdevs, et al.
Publicado: (2017)

All That Glitters Is Not Gold: The Same Sleep Time, but Different Diabetogenic Outcomes
por: Kim, Bohye, et al.
Publicado: (2023)

In vivo efficacy of pitavastatin combined with itraconazole against Aspergillus fumigatus in silkworm models
por: Majima, Hidetaka, et al.
Publicado: (2023)

Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo
por: Chen, Ya-Hui, et al.
Publicado: (2020)

Pitavastatin in cardiometabolic disease: therapeutic profile
por: Masana, Luis
Publicado: (2013)

Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)

COMPARATIVE DIABETOGENIC ACTION OF THE HYPOPHYSIS FROM VARIOUS ANIMALS
por: Houssay, B. A., et al.
Publicado: (1942)

Diabetogenic Effect of Statins: A Double-Edged Sword?
por: Yoon, Ji Sung, et al.
Publicado: (2013)

Brève : Sars-CoV-2, agent diabétogène ?
por: Dalmat, Yann-Mickael
Publicado: (2021)

Pitavastatin: evidence for its place in treatment of hypercholesterolemia
por: Alagona, Peter
Publicado: (2010)

Effect of Pitavastatin on Vascular Reactivity in Hypercholesterolemic Rabbits
por: de Almeida, Eros Antonio, et al.
Publicado: (2014)

Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial
por: Tsujita, Kenichi, et al.
Publicado: (2023)

Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment
por: Koo, Yeryung, et al.
Publicado: (2023)

Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation
por: Sarfraz, Rai Muhammad, et al.
Publicado: (2017)

Improved Pharmacodynamic Potential of Rosuvastatin by Self-Nanoemulsifying Drug Delivery System: An in vitro and in vivo Evaluation
por: Verma, Ravinder, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e93tcc54k23fuj3jvi4h30a0u3